The government has announced that it will be giving COVID-19 vaccines free of cost across the country. However, Serum Institue of India’s CEO Adar Poonawalla stated that if the government allows sale in the retail, the vaccine will be commercially available at ₹ 1,000 per dose.
According to reports, India’s drugs regulator on Sunday, approved Oxford COVID-19 vaccine Covishield – manufactured by the Serum Institute – and indigenously developed Covaxin of Bharat Biotech, for restricted emergency use in the country, paving the way for a massive inoculation drive.
“We are giving it in a very special price of ₹200 for the first hundred million doses. Then there will be tendering and then different prices will be available,” Mr Poonawalla told NDTV.
“But let me just say – whatever we give to the government – they are going to provide it free to the people of India and when we subsequently sell it in the private market, the MRP is going to be ₹ 1,000 per shot,” he said
The Drugs Controller General of India (DCGI) granted approval on the basis of recommendations by a COVID-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). This clears the way for the roll-out of at least two vaccines in India in the coming days.
Serum and Bharat Biotech vaccines have to be administered in two doses and these vaccines have to be stored at 2-8° C. The Serum Institute of India, the world’s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield, while Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)…Read more>>